3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myeloid, Acute
4
Lymphoma
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Myelodysplastic Syndromes
2
Leukemia, Lymphoid
2
Leukemia, Biphenotypic, Acute
2
Leukemia
2
Hematologic Diseases
2
Bone Marrow Failure Disorders
2
Anemia, Refractory, with Excess of Blasts
2
Shwachman-Diamond Syndrome
1
Preleukemia
1
Precancerous Conditions
1
Pancytopenia
1
Osteosclerosis
1
Osteopetrosis
1
Osteochondrodysplasias
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Musculoskeletal Diseases
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphatic Diseases
1
Leukocyte Disorders
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Cyclophosphamide
23
fludarabine phosphate
19
Whole-Body Irradiation
17
fludarabine
16
Melphalan
16
Tacrolimus
14
Busulfan
14
Peripheral Blood Stem Cell Transplantation
11
Mycophenolic Acid
11
Alemtuzumab
9
Cyclosporine
7
Methotrexate
6
Antilymphocyte Serum
6
thymoglobulin
4
Stem Cell Transplantation
4
Thiotepa
3
Methylprednisolone
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
AP 1903 reagent
3
sargramostim
2
Transplantation
2
Sirolimus
2
Rituximab
2
Mesna
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Hematopoietic Stem Cell Transplantation
2
Flow Cytometry
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Bone Marrow Transplantation
×
Classical hematology
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled